<DOC>
	<DOCNO>NCT02159378</DOCNO>
	<brief_summary>The prevalence gestational diabetes estimate 2 6 % , much high specific population . The specific treatment gestational diabetes ( diet , control weight gain , self monitor glucose , insulin therapy ) reduce complication severe perinatal , fetal macrosomia , preeclampsia compare abstention therapy , without additional risk caesarean section . Several early study show determination fructosamine bad way diagnosis Gestational Diabetes . However , study investigate relationship determination serum fructosamine put insulin case Gestational Diabetes . The purpose study determine serum fructosamines rate predictive marker start insulin patient suffer Gestational Diabetes</brief_summary>
	<brief_title>Fructosamines Gestational Diabetes ( FRUCTO )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes , Gestational</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Age â‰¥18 year Ongoing pregnancy start date pregnancy know confirm ultrasound 1st Quarter perform 10 14 week measurement crownrump length Hospitalization GD 's discovery whatever term pregnancy ( GD define national recommendation CNGOF ) Not oppose participate study Pregnancy uncertain term ( absence early ultrasound ) Previous diabetes pregnancy ( type 1 2 ) Multiple Pregnancy No affiliation social security scheme Woman measure legal protection</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Gestational Diabetes</keyword>
	<keyword>Fructosamines</keyword>
	<keyword>Insulin treatment</keyword>
</DOC>